ArticleCureus2025
Emerging Antifungal Resistance in Dermatophytosis: A Clinicomycological Study From North India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Resistance and Recalcitrance in Dermatophytosis: Mechanistic and Clinical Considerations for Keratinized Tissues.Antibiotics (Basel, Switzerland) · 2026Review
- Biological Activity of Stilbenoids Against Fungal, Parasitic, and Viral Pathogens.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Dermatophytosis is a common superficial fungal infection affecting the skin, hair, and nails and is increasingly being recognized as a public health challenge. In recent years, there has been a noticeable increase in chronic and recurrent cases, possibly due to changing patterns of antifungal resistance, misuse of medications, and host-related factors. This study aimed to assess the demographic and clinical characteristics of patients with dermatophytosis, evaluate treatment history and recurrence, and analyze antifungal resistance patterns. Material and methods A total of 130 patients clinically diagnosed with dermatophytosis and attending the Dermatology Outpatient Department were included in this observational study. After obtaining informed consent, detailed data on demographic factors, clinical presentation using the Dermatophytosis Severity Score (DSS), treatment history, and recurrence were recorded. Fungal cultures and antifungal susceptibility testing were performed on positive isolates to evaluate resistance patterns. Results The most affected age group was 31-45 years (38; 42.2%), with a male predominance (52; 57.8%). Most patients were rural residents (72; 80%) and uneducated (58; 64.4%), with homemakers (32; 35.6%) and students (19; 21.1%) forming the major occupational groups. Disease duration was mostly one to two years (40; 44.4%), and recurrent infections were common (83; 92.2%), even with mild severity scores (DSS 1-10 in 79 individuals; 87.8%).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.